Eucerin Itch Relief Intensive Calming

Description

Eucerin Itch Relief Intensive Calming Lotion is formulated to provide relief for dry, itchy skin. This menthol external analgesic lotion offers immediate soothing and calming effects, delivering up to 12 hours of itch relief. Enriched with ceramides, it supports skin hydration and barrier function. The lotion is free from fragrances and dyes, making it suitable for sensitive skin. It is designed for dermatological skincare, addressing the needs of individuals experiencing discomfort from dry skin conditions.

Uses and Indications

This drug is indicated for the temporary relief of itching associated with minor skin irritations. It provides immediate relief and calms dry, itchy skin, offering up to 12 hours of itch relief. The formulation delivers a soothing and cooling effect to enhance patient comfort.

Dosage and Administration

For adults and children aged 8 years and older, the recommended application is to the affected area not more than 3 to 4 times daily.

For children under 8 years of age, it is advised to consult a healthcare professional prior to use.

Contraindications

There are no specific contraindications listed for this product. However, it is advised to discontinue use and consult a healthcare professional if any of the following occur: worsening of the condition, symptoms persisting beyond 7 days, symptoms resolving and then recurring within a few days, or if irritation develops. Additionally, during use, contact with the eyes should be avoided.

Warnings and Precautions

For external use only. It is imperative to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

Healthcare professionals should advise patients to discontinue use and consult a physician if any of the following occur: the condition worsens, symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. Additionally, if any irritation develops, patients should stop using the product and seek medical advice.

In cases of ingestion, it is crucial to obtain emergency medical help or contact a Poison Control Center immediately.

Side Effects

Patients should be aware that the product is intended for external use only.

In clinical practice, it is advised that patients stop using the product and consult a healthcare professional if any of the following occur: the condition worsens, symptoms persist for more than 7 days, symptoms resolve and then recur within a few days, or if any irritation develops. These recommendations are based on clinical observations and are intended to ensure patient safety and effective management of their condition.

Drug Interactions

No drug interactions have been identified in the available data. Additionally, there are no interactions noted between drugs and laboratory tests. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Eucerin Itch Relief Intensive Calming (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 8 years and older may apply the medication to the affected area no more than 3 to 4 times daily. For children under 8 years of age, it is advised to consult a doctor prior to use.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The safety of Eucerin Itch Relief Intensive Calming Lotion during pregnancy has not been established, as the prescribing information does not provide specific data regarding its use in pregnant patients. There are no documented safety concerns, dosage modifications, or special precautions outlined for this population. Healthcare professionals should consider the lack of available data when advising women of childbearing potential and weigh the potential benefits against any unknown risks to fetal outcomes. It is recommended that pregnant patients consult their healthcare provider before using this product.

Lactation

There are no specific statements or information regarding nursing mothers or lactation in the provided drug insert for Eucerin Itch Relief Intensive Calming Lotion. Therefore, the effects on lactating mothers and breastfed infants are not established. Healthcare professionals should consider this lack of data when advising lactating mothers on the use of this product.

Renal Impairment

Patients with renal impairment may require dosage adjustments to ensure safety and efficacy. It is essential to monitor renal function tests in individuals with kidney problems to assess their renal status. Additionally, a reduced dose should be considered for patients with decreased creatinine clearance to mitigate the risk of adverse effects associated with impaired renal function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution when administering the medication. It is essential to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, immediate medical attention should be sought. Healthcare providers should implement supportive measures as necessary, which may include symptomatic treatment and monitoring of vital signs.

Due to the lack of detailed overdosage information, it is recommended that healthcare professionals refer to established clinical guidelines and protocols for managing overdose situations relevant to the specific medication in question. Additionally, contacting a poison control center may provide further guidance on appropriate management strategies.

Continued vigilance and patient assessment are crucial in mitigating potential risks associated with overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be instructed to discontinue use and consult a doctor if their condition worsens. Additionally, they should be informed to stop using the product and seek medical advice if symptoms persist for more than 7 days or if symptoms resolve and then recur within a few days.

It is important for healthcare providers to emphasize that patients should cease use and consult a healthcare professional if any irritation occurs while using the product. Furthermore, patients should be cautioned to avoid contact with the eyes during application.

Storage and Handling

The product is supplied in a container that must be stored at room temperature. It is essential to protect the product from light exposure to maintain its integrity. The bottle should be kept tightly closed when not in use to prevent contamination and degradation. Additionally, the product should be discarded after opening to ensure safety and efficacy.

Additional Clinical Information

Patients aged 8 years and older are advised to apply the product to the affected area no more than 3 to 4 times daily. For children under 8 years of age, consultation with a doctor is recommended prior to use.

Clinicians should counsel patients to avoid contact with the eyes while using the product. Patients should discontinue use and seek medical advice if the condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. Additionally, it is important to keep the product out of reach of children; if ingested, medical assistance or contact with a Poison Control Center should be sought immediately.

Drug Information (PDF)

This file contains official product information for Eucerin Itch Relief Intensive Calming, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)